Srinibas Pradhan Constructions IPO...
28 Feb, 2026
Entero Healthcare Solutions Limited IPO
Entero Healthcare Solutions Ltd. (EHSL) is amongst the top three healthcare products distributors in India in terms of revenue in Financial Year 2022. Further, it also achieved the fastest scale-up of operations among healthcare products distributors in India (between Financial Year 2019 to Financial Year 2022). The Company was founded with the vision to create an organized, Pan-India, technology driven and integrated healthcare products distribution platform that can add value to the entire healthcare ecosystem. The company adds value to the healthcare product manufacturers that work with it by providing them reach and accessibility to pharmacies, hospitals and clinics through EHSL's integrated and technology driven, Pan-India healthcare products distribution platform.
Entero Healthcare Solutions IPO is a book-built issue of Rs 1,600.00 crores. The issue is a combination of fresh issue of 0.79 crore shares aggregating to Rs 1,000.00 crores and offer for sale of 0.48 crore shares aggregating to Rs 600.00 crores. Entero Healthcare Solutions IPO price band is set at ₹1195 to ₹1258 per share. The minimum lot size for an application is 11 Shares. ICICI Securities Limited, Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd), Jefferies India Private Limited, Jm Financial Limited and SBI Capital Markets Limited are the book running lead managers of the Entero Healthcare Solutions IPO, while Link Intime India Private Ltd is the registrar for the issue.
WHAT IS GMP?
GMP (Grey Market Premium) is the difference between the IPO price and the grey market price. It is the premium amount paid for the traded IPO shares. It plays an important role in IPOs as it reflects how the IPO would react on the listing day.
A grey market is a place where shares/stocks are traded before being listed officially on the stock exchange.
Entero Healthcare Solutions Limited IPO GMP
| GMP Date | IPO Price | GMP | Last Updated |
|---|---|---|---|
| - | - | - | - |
**The GMP prices displayed here are solely for informational purposes related to the grey market news. India IPO does not engage in or facilitate grey market trading, nor are these rates (sub2) indicative of any trading activity. We also do not recommend or endorse participation in the grey market.**
Entero Healthcare Solutions Limited IPO Details
| Detail | Description |
|---|---|
| IPO Date | February 9, 2024 to February 13, 2024 |
| Listing Date | February 16, 2024 |
| Face Value | ₹10 per share |
| Price Band | ₹1195 to ₹1258 per share |
| Lot Size | 11 Shares |
| Total Issue Size | 12,718,600 shares (aggregating up to ₹1,600.00 Cr) |
| Fresh Issue | 7,949,125 shares (aggregating up to ₹1,000.00 Cr) |
| Offer for Sale | 4,769,475 shares of ₹10 (aggregating up to ₹600.00 Cr) |
| Employee Discount | Rs 119 per share |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| Share holding pre issue | 39,577,705 |
| Share holding post issue | 47,526,830 |
Entero Healthcare Solutions Limited IPO Timeline
| Detail | Description |
|---|---|
| IPO Open Date | Friday, February 9, 2024 |
| IPO Close Date | Tuesday, February 13, 2024 |
| Basis of Allotment | Wednesday, February 14, 2024 |
| Initiation of Refunds | Thursday, February 15, 2024 |
| Credit of Shares to Demat | Thursday, February 15, 2024 |
| Listing Date | Friday, February 16, 2024 |
| Cut-off time for UPI mandate confirmation | 5 PM on February 13, 2024 |
Entero Healthcare Solutions Limited IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 11 | ₹13,838 |
| Retail (Max) | 14 | 154 | ₹193,732 |
| S-HNI (Min) | 15 | 165 | ₹207,570 |
| S-HNI (Max) | 72 | 792 | ₹988,416 |
| B-HNI (Min) | 73 | 803 | ₹1,010,174 |
Entero Healthcare Solutions Limited IPO Promoter Holding
| Share Holding Pre Issue | Share Holding Post Issue |
|---|---|
| Share Holding Pre Issue | 77.11% |
| Share Holding Post Issue | - |
Competitive Strength:
- -
Entero Healthcare Solutions Limited IPO Financial Information
| Period Ended | Assets | Total Income | Profit After Tax | Net Worth | Reserves and Surplus | Total Borrowing | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30 Sep 2023 | 1,505.95 | 1,898.98 | 11.64 | 660.54 | - | 488.68 | ||||||||||||||||||||||||||||||||||
| 31 Mar 2023 | 1,308.73 | 3,305.72 | -11.10 | 597.66 | - | 373.52 | ||||||||||||||||||||||||||||||||||
| 31 Mar 2022 | 1,125.98 | 2,526.55 | -29.44 | 563.22 | - | 285.03 | ||||||||||||||||||||||||||||||||||
| 31 Mar 2021 | 833.79 | 1,783.67 | -15.35 | 487.06 | - | 141.70 | ||||||||||||||||||||||||||||||||||
| Amount in ₹ Crore | ||||||||||||||||||||||||||||||||||||||||
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | -2.66% |
| ROCE | 6.06% |
| Debt/Equity | 0.45 |
| RoNW | -1.86% |
| P/BV | 7.22 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 9.7 | |
| P/E (x) | 129.75 |
Objectives of Entero Healthcare Solutions IPO
The Company proposes to utilize the Net Proceeds from the Fresh Issue towards funding the following objectives:
- ● Repayment/prepayment, in full or part, of certain borrowings availed of by the company and its Subsidiaries.
- ● Funding the long term working capital requirements.
- ● Pursuing inorganic growth initiatives through acquisitions.
- ● General corporate purposes.
Entero Healthcare Solutions IPO Review
The company is one of the leading and fastest growing healthcare product distributors in India. EHSL marked losses for FY21 to FY23 and turned the corner for H1 of FY24. Based on annualized FY24 earnings, the issue appears aggressively priced, discounting all near term positives. Well-informed/risk seeker/cash surplus investors may park funds for the long term reward as it holds prospects going forward.
RHP:
View RHPDRHP:
View DRHPRead more :
Frequently Asked Questions (FAQs)
-
What Is The Size Of The Entero Healthcare Solutions IPO?
Entero Healthcare Solutions IPO consists of a fresh issue of shares worth INR 1000 crores and an offer to sell 85.97 crores of existing equity shares. The company aims to repay debt, fund working capital, pursue acquisitions, and ensure corporate sustainability.
-
When will Entero Healthcare Solutions IPO Subscription will start?
The IPO subscription starts on February 9, 2024 for NII, QIB and Retail Investors.
-
When will Entero Healthcare Solutions Ltd's IPO be allotted?
The shares of Entero Healthcare Solutions IPO will be credited on February 15, 2024.
-
What minimum lot size can retail investors subscribe to?
The lot size for the IPO is 11 shares per lot.
-
When will Entero Healthcare Solutions Ltd list on exchanges?
Entero Healthcare Solutions Ltd IPO will be listed on the NSE and the BSE. The listing date is February 16, 2024.
